![Cynthia Butitta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cynthia Butitta
Direktor/Vorstandsmitglied bei
UROGEN PHARMA LTD.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Cynthia M.
Butitta is the founder of Butitta Consulting Services LLC, founded in 1997.
Ms. Butitta was the founder of Altair Capital Associates LLC, founded in 1997, and served as Partner from 1998 to 2001.
Current jobs include Independent Director at UroGen Pharma Ltd. since 2017, Independent Director at Autolus Ltd. since 2018, Independent Non-Executive Director at Autolus Therapeutics Plc since 2018, and Independent Director at Olema Pharmaceuticals, Inc. since 2020.
Former jobs include Director at Catalyst Semiconductor, Inc. from 2000 to 2002, Independent Director at Century Therapeutics, Inc. from 2021 to 2025, Director at Century Therapeutics, Inc., Chief Financial Officer & VP-Administration at InSite Vision, Inc. in 1995, CFO, VP-Finance & Administration at Connetics Corp.
from 1995 to 1997, Chief Financial Officer & Senior Vice President at NextWave Pharmaceuticals, Inc. from 2011 to 2012, Chief Operating Officer at Kite Pharma, Inc. from 2016 to 2017, and Chief Financial & Operating Officer at Telik, Inc. from 2001 to 2010.
Education includes undergraduate studies at Edgewood College and an MBA from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.04.2026 | 83 876 ( 0,1 % ) | 1 Mio $ | 31.05.2026 | |
| 12.06.2025 | 98 936 ( 0,05 % ) | 242 393 $ | 31.05.2026 | |
| 31.03.2026 | 2 000 ( 0 % ) | 56 260 $ | 31.05.2026 | |
AUTOLUS THERAPEUTICS PLC 0,01 % | 18.03.2026 | 10 000 ( 0,01 % ) | 18 700 $ | 31.05.2026 |
Aktive Positionen von Cynthia Butitta
| Unternehmen | Position | Beginn |
|---|---|---|
| UROGEN PHARMA LTD. | Direktor/Vorstandsmitglied | 01.10.2017 |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.03.2018 |
| OLEMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.08.2020 |
Butitta Consulting Services LLC | Gründer | 13.11.2009 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Direktor/Vorstandsmitglied | 15.03.2018 |
Ehemalige bekannte Positionen von Cynthia Butitta
| Unternehmen | Position | Ende |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 14.08.2025 |
| KITE PHARMA INC | Finanzdirektor/CFO | 16.05.2016 |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Finanzdirektor/CFO | 01.12.2012 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Finanzdirektor/CFO | 01.12.2010 |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Cynthia Butitta
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
InSite Vision, Inc.
 InSite Vision, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceutical products | Health Technology |
Catalyst Semiconductor, Inc.
 Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Provides semiconductor products | Electronic Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and commercializing novel small molecule drugs to treat serious diseases | Health Technology |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Edgewood College
 Edgewood College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Butitta Consulting Services LLC | |
Altair Capital Associates LLC | |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
